An Update on Direct Oral Anticoagulation

Tags: Online learning, Medication therapy management

Recent Canadian data shows the trend that while frequency of oral anticoagulation therapy has been relatively stable over the last number of years, the use of warfarin is decreasing, and the use of Direct Oral Anticoagulants (DOACs) is increasing. Hence appropriate use of DOACs has become increasingly important. This program will review the most recent information on using DOACs in specific patient populations such as management of venous thromboembolism (VTE) in patients with cancer or obesity, and the pharmacist’s role in monitoring and follow-up of DOACs therapy.

Program outline

This program consists of the 1-hour length online module with final exam and evaluation:

  • An Update on Oral Anticoagulation (1 hour)
  • Declaration of Completion of Online Module
  • Final Multiple-choice Exam (0.25 hour)
  • Program’s Evaluation


Continuing Education Units:

  • Number of CEUs:  1.25
  • Accreditation #: 8003-2018-2621-I-P
  • Accreditation Expiry Date: November 28, 2019

Course Availability:

You must complete the course one day before its expiry date; access will be removed after this point.

Learning Format: 

  • Online, didactic learning module
  • Case study analysis and discussion

Learner Assessment:

  • Multiple choice assessment

How to register: To register, please scroll to the bottom of the page and click on the “PROGRAM AND PRICING”; a drop-down will open with pricing information for members and non-members*. Select the option that applies to you, then click on "add to cart" to start the registration process.

*Not a member? OPA members receive significant discounts on professional development. Find out about becoming a member here.

If you’re a pharmacist, you may be eligible for funding from the Allied Health Professional Development Fund (AHPDF). Click here for more information, and to apply.

Learning objectives

Upon completion of this program, participants will be able to:

  • Summarize recent evidence for use of DOACs in practice
  • Describe considerations for the use of DOACs in specific patient populations
  • Identify tools to support the pharmacist’s role in ensuring optimal efficacy and safety of oral anticoagulant therapy

Program Completion

To receive the letter of completion for this program, participants will be required to complete the following requirements until one day before its expiry date: 

  • Complete the program’s online modules (instructions will be emailed to you separately after registration).
  • Complete the multiple-choice exam and achieve a score of 70 per cent or more within a maximum of two attempts.
  • Complete the program’s evaluation.

Pre-requisites and Target Audience

There are no pre-requisites for this program. Pharmacists and pharmacy students would find this learning useful and applicable.

Subject Matter Experts: 

  • Natalie Crown, RPh, ACPR (BScPhm, PharmD)
  • Bill Bartle, RPh (BScPhm, PharmD)
  • Jonathan Hunchuck, RPh, ACPR (BScPhm, PharmD)

Last updated: November 26, 2018

Inquiries: Please contact OPA’s professional development team by phone at 416-441-0788, option 3 (toll-free in Ontario at 1-877-341-0788, option 3), or by email at

Cancellation policy: Requests for cancellations must be submitted in writing to no later than five days after access to the program has been emailed to you. A $10 (+HST) administration and processing fee will apply. Cancellations will not be permitted once log-in to access the program material has been initiated. Program registration fees will not be refunded after the cancellation deadline.

Protecting your privacy: Your privacy is important to us. Some information you provide to OPA in program registration forms and exercises may be considered personal information. OPA collects, uses, and shares the information contained in program registration forms and exercises for the sole purposes of processing your registration, issuing certificates/letters of completion, awarding continuing education credits, and delivering OPA services, programs, and publications to you.

Learners’ code of conduct: By registering for an OPA education program, you agree to follow OPA’s Learners’ Code of Conduct. For further details click here

Event Date: Recurring | City: Online | Venue: Online

Pricing and Registration
Member Rate
An Update on Direct Oral Anticoagulants   $20.00 Add to Cart 
Non-Member Rate
An Update on Direct Oral Anticoagulants   $40.00 Add to Cart 
Back to top